Houston, TX, United States of America

Francis J Giles

USPTO Granted Patents = 6 

Average Co-Inventor Count = 2.6

ph-index = 3

Forward Citations = 67(Granted Patents)


Company Filing History:


Years Active: 2003-2005

Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of Francis J. Giles

Introduction

Francis J. Giles is a notable inventor based in Houston, TX, with a significant contribution to the field of pharmaceuticals. He holds a total of six patents, showcasing his innovative approach to addressing critical health issues.

Latest Patents

Among his latest patents is a method for the treatment or prevention of viral infections using nucleoside analogues. This patent focuses on treating viral infections such as herpes simplex virus, varicella zoster virus, respiratory syncytial virus, and cytomegalovirus. The method involves administering a therapeutically effective amount of a compound of formula I or a pharmaceutically acceptable salt thereof. The compounds and salts can also be utilized to inhibit viral replication of these viruses in cells. Another significant patent is a pharmaceutical combination for the treatment of cancer, which highlights his commitment to advancing medical science.

Career Highlights

Throughout his career, Francis J. Giles has worked with prominent companies such as Shire Biochem, Inc. and Biochem Pharma Inc. His work in these organizations has contributed to the development of innovative treatments that address various health challenges.

Collaborations

He has collaborated with notable coworkers, including Jacques Jolivet and Henriette Gourdeau, further enhancing the impact of his work in the pharmaceutical industry.

Conclusion

Francis J. Giles exemplifies the spirit of innovation in the field of pharmaceuticals, with his patents reflecting a dedication to improving health outcomes. His contributions continue to influence the development of effective treatments for viral infections and cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…